Clinical and Biological Characteristics of Hidradenitis Suppurativa

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT03967600
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
13 Years - N/A
Healthy Volunteers
Accepted

Study Details

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Key Dates

Start date
Jul 15, 2016
Status verified
Apr 2026
Primary completion
Jul 15, 2026
Completion
Jul 15, 2026

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Hidradenitis Suppurativa Patients
    Patients with physician diagnosed Hidradenitis Suppurativa
  • Arm: Healthy Volunteers
    Healthy volunteers without any skin conditions or recent history of antibiotic use.

Primary Outcome Measure

The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa. [ Time Frame: 2016-2026 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94115
Maia Paul, MPH
[email protected]
415-502-4741
Haley B Naik, MD, MHSc, FAAD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

By condition
Hidradenitis suppurativa
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
University of California, San Francisco· San Francisco, CA

Related Studies